Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 7, 2013, Pages 1310-1315

  Antonelli, Alessandro ^a   Arrighi, Nicola ^a   Corti, Serena ^a   Zanotelli, Tiziano ^a   Cozzoli, Alberto ^a   Cosciani Cunico, Sergio ^a   Simeone, Claudio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Diabetes mellitus; Prognosis; Renal cell carcinoma

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIABETIC PATIENT; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GENDER; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY;

DIABETES MELLITUS; PROGNOSIS; RENAL CELL CARCINOMA;

AGE FACTORS; AGED; CARCINOMA, RENAL CELL; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; NEPHRECTOMY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84884669633     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.12.013     Document Type: Article

References (27)

1. Larsson S.C., Mantzoros C.S., Wolk A. Diabetes mellitus and risk of breast cancer: A meta-analysis. Int J Cancer 2007, 121:856-862.
2. Larsson S.C., Orsini N., Wolk A. Diabetes mellitus and risk of colorectal cancer: A meta-analysis. J Natl Cancer Inst 2005, 97:1679-1687.
3. Friberg E., Orsini N., Mantzoros C.S., et al. Diabetes mellitus and risk of endometrial cancer: A meta-analysis. Diabetologia 2007, 50:1365-1374.
4. El-Serag H.B., Hampel H., Javadi F. The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006, 4:369-380.
5. Huxley R., Ansary-Moghaddam A., Berrington de Gonzalez A., et al. Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. Br J Cancer 2005, 92:2076-2083.
6. Woolcott C.G., Maskarinec G., Haiman C.A., et al. Diabetes and urothelial cancer risk: The multiethnic cohort study. Cancer Epidemiol 2011, 35:551-554.
7. Larsson S.C., Wolk A. Diabetes mellitus and incidence of kidney cancer: A meta-analysis of cohort studies. Diabetologia 2011, 54:1013-1018.
8. Zhou X.H., Qiao Q., Zethelius B., et al. Diabetes, prediabetes, and cancer mortality. Diabetologia 2010, 53:1867-1876.
9. Barone B.B., Hsin-Chieh Y., Snyder C.F., et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus. JAMA 2008, 300:2754-2764.
10. van de Poll-Franse L.V., Houterman S., Janssen-Heijnen M.L., et al. Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis. Int J Cancer 2007, 120:1986-1992.
11. Vavallo A., Lucarelli G., Tedeschi M., et al. Diabetes mellitus is a risk factor for recurrence and mortality in patients with renal cell carcinoma. Eur Urol 2011, 10(Suppl 2):139-140.
12. Patard J.J., Leray E., Cindolo L., et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 2004, 172:858-862.
13. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Int Med 1999, 130:461-470.
14. Greene F.L., Gospodarowicz M., Wittekend C., et al. American Joint Committee on Cancer (AJCC) Staging Manual 2002, Springer, Philadelphia, PA. 6th ed.
15. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs 2004, IARC Press, Lyon. J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn (Eds.).
16. Fuhrman S., Lasky L.C., Limas L. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6:655-663.
17. Accessed Jun 2011. http://www.who.int/diabetes/facts/world_figures/en.
18. Willi C., Bodenmann P., Ghali W.A., et al. Active smoking and the risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2007, 298:2654-2664.
19. Abdullah A., Peeters A., de Courten M., et al. The magnitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studies. Diabetes Res Clin Pract 2010, 89:309-319.
20. Hunt J.D., van der Hel O.L., McMillan G.P., et al. Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies. Int J Cancer 2005, 114:101-108.
21. Chow W.H., Gridley G., Fraumeni J.F., et al. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000, 343:1305-1311.
22. Pollak M. Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer 2008, 8:915-928.
23. Rajpathak S.N., Gunter M.J., Wylie-Rosett J., et al. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev 2009, 25:3-12.
24. Oba S., Nagata C., Nakamura K., et al. Self- reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: A population-based prospective cohort study in Japan. J Epidemiol 2008, 18:197-203.
25. Coughlin S.S., Calle E.E., Teras L.R., et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004, 159:1160-1167.
26. Noh G.Y., Hwang D.Y., Choi Y.H., et al. Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol 2010, 26:424-428.
27. Howell J., Yiu M., Gibson R., et al. Type 2 diabetes does not worsen prognosis in hepatocellular carcinoma. Clin Res Hepat Gastroenterol 2011, 35:214-220.